Pancreatic cancer is one of the deadliest forms of cancer because it is difficult to diagnose and only presents with symptoms in the later stages. In the future, a laboratory test developed at the Greifswald University Medicine could make an early detection of this type of cancer and consequently a faster and better treatment possible.
In this interview with MEDICA-tradefair.com, Prof. Julia Mayerle talks about the human metabolome and the development of mass spectrometric measurement to detect tumors.
Prof. Mayerle, what does early detection of pancreatic cancer presently look like?
Prof. Julia Mayerle: In 2014, 48,000 patients received in-patient treatment for pancreatic cancer in Germany. This type of cancer is very malignant and responds so poorly to medical treatment or radiation therapy to where only between four and eight percent of patients are still alive five years after receiving the initial diagnosis. By 2030, it is estimated pancreatic cancer will be the third leading cause of cancer-related deaths. ...
Read the complete interview at MEDICA-tradefair.com!